| UniProt ID | RALA_HUMAN | |
|---|---|---|
| UniProt AC | P11233 | |
| Protein Name | Ras-related protein Ral-A | |
| Gene Name | RALA | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 206 | |
| Subcellular Localization |
Cell membrane Lipid-anchor Cytoplasmic side. Cleavage furrow . Midbody, Midbody ring . Predominantly at the cell surface in the absence of LPA. In the presence of LPA, colocalizes with LPAR1 and LPAR2 in endocytic vesicles (PubMed:19306925). May |
|
| Protein Description | Multifunctional GTPase involved in a variety of cellular processes including gene expression, cell migration, cell proliferation, oncogenic transformation and membrane trafficking. Accomplishes its multiple functions by interacting with distinct downstream effectors. Acts as a GTP sensor for GTP-dependent exocytosis of dense core vesicles. The RALA-exocyst complex regulates integrin-dependent membrane raft exocytosis and growth signaling. [PubMed: 20005108 Key regulator of LPAR1 signaling and competes with GRK2 for binding to LPAR1 thus affecting the signaling properties of the receptor. Required for anchorage-independent proliferation of transformed cells] | |
| Protein Sequence | MAANKPKGQNSLALHKVIMVGSGGVGKSALTLQFMYDEFVEDYEPTKADSYRKKVVLDGEEVQIDILDTAGQEDYAAIRDNYFRSGEGFLCVFSITEMESFAATADFREQILRVKEDENVPFLLVGNKSDLEDKRQVSVEEAKNRAEQWNVNYVETSAKTRANVDKVFFDLMREIRARKMEDSKEKNGKKKRKSLAKRIRERCCIL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 7 | Ubiquitination | -MAANKPKGQNSLAL -CCCCCCCCCCCCCC | 74.80 | 33845483 | |
| 11 | Phosphorylation | NKPKGQNSLALHKVI CCCCCCCCCCCEEEE | 13.71 | 30266825 | |
| 16 | Malonylation | QNSLALHKVIMVGSG CCCCCCEEEEEECCC | 34.02 | 26320211 | |
| 19 | Sulfoxidation | LALHKVIMVGSGGVG CCCEEEEEECCCCCC | 2.90 | 21406390 | |
| 22 | Phosphorylation | HKVIMVGSGGVGKSA EEEEEECCCCCCHHH | 22.44 | 25159151 | |
| 43 | Phosphorylation | YDEFVEDYEPTKADS HHHHHHCCCCCCCHH | 15.42 | 25884760 | |
| 46 | O-linked_Glycosylation | FVEDYEPTKADSYRK HHHCCCCCCCHHCCC | 27.24 | 8858106 | |
| 50 | Phosphorylation | YEPTKADSYRKKVVL CCCCCCHHCCCEEEE | 31.53 | 24719451 | |
| 51 | Phosphorylation | EPTKADSYRKKVVLD CCCCCHHCCCEEEEC | 27.31 | - | |
| 54 | Ubiquitination | KADSYRKKVVLDGEE CCHHCCCEEEECCCE | 28.69 | 22053931 | |
| 75 | Phosphorylation | DTAGQEDYAAIRDNY CCCCCCCHHHHHHCC | 9.36 | 25884760 | |
| 82 | Phosphorylation | YAAIRDNYFRSGEGF HHHHHHCCEECCCCE | 12.50 | - | |
| 85 | Phosphorylation | IRDNYFRSGEGFLCV HHHCCEECCCCEEEE | 31.15 | - | |
| 115 | 2-Hydroxyisobutyrylation | REQILRVKEDENVPF HHHHHCCCCCCCCCE | 53.68 | - | |
| 128 | Ubiquitination | PFLLVGNKSDLEDKR CEEEECCHHHHCCHH | 39.14 | 24816145 | |
| 129 | Phosphorylation | FLLVGNKSDLEDKRQ EEEECCHHHHCCHHC | 51.97 | 23312004 | |
| 134 | Ubiquitination | NKSDLEDKRQVSVEE CHHHHCCHHCCCHHH | 35.04 | 33845483 | |
| 138 | Phosphorylation | LEDKRQVSVEEAKNR HCCHHCCCHHHHHHH | 18.57 | 25159151 | |
| 143 | Ubiquitination | QVSVEEAKNRAEQWN CCCHHHHHHHHHHHC | 50.69 | 33845483 | |
| 153 | Phosphorylation | AEQWNVNYVETSAKT HHHHCCCEEECCHHH | 8.72 | 22817900 | |
| 159 | Ubiquitination | NYVETSAKTRANVDK CEEECCHHHCCCHHH | 38.01 | 23000965 | |
| 159 | Ubiquitination | NYVETSAKTRANVDK CEEECCHHHCCCHHH | 38.01 | 21890473 | |
| 166 | 2-Hydroxyisobutyrylation | KTRANVDKVFFDLMR HHCCCHHHHHHHHHH | 36.34 | - | |
| 179 | Ubiquitination | MREIRARKMEDSKEK HHHHHHHHHHHHHHH | 45.73 | 24816145 | |
| 183 | Phosphorylation | RARKMEDSKEKNGKK HHHHHHHHHHHHCHH | 29.43 | 17540176 | |
| 183 | Dephosphorylation | RARKMEDSKEKNGKK HHHHHHHHHHHHCHH | 29.43 | 17540176 | |
| 194 | Phosphorylation | NGKKKRKSLAKRIRE HCHHHHHHHHHHHHH | 37.28 | 17540176 | |
| 194 | Dephosphorylation | NGKKKRKSLAKRIRE HCHHHHHHHHHHHHH | 37.28 | 17540176 | |
| 203 | Methylation | AKRIRERCCIL---- HHHHHHHHCCC---- | 1.13 | - | |
| 203 | Geranylgeranylation | AKRIRERCCIL---- HHHHHHHHCCC---- | 1.13 | 1903399 | |
| 203 | Geranylgeranylation | AKRIRERCCIL---- HHHHHHHHCCC---- | 1.13 | 1903399 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 194 | S | Phosphorylation | Kinase | AURKA | O14965 | GPS |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RALA_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RALA_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Prenylation | |
| Reference | PubMed |
| "Geranylgeranyltransferase I inhibitors target RalB to inhibitanchorage-dependent growth and induce apoptosis and RalA to inhibitanchorage-independent growth."; Falsetti S.C., Wang D.A., Peng H., Carrico D., Cox A.D., Der C.J.,Hamilton A.D., Sebti S.M.; Mol. Cell. Biol. 27:8003-8014(2007). Cited for: SUBCELLULAR LOCATION, ISOPRENYLATION, ISOPRENYLATION AT CYS-203, ANDMUTAGENESIS OF CYS-203 AND LEU-206. | |
| "Carboxyl-terminal isoprenylation of ras-related GTP-binding proteinsencoded by rac1, rac2, and ralA."; Kinsella B.T., Erdman R.A., Maltese W.A.; J. Biol. Chem. 266:9786-9794(1991). Cited for: ISOPRENYLATION AT CYS-203. | |